4.7 Article

Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

TGF-beta requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy

Johanna Abrigo et al.

BIOLOGICAL CHEMISTRY (2018)

Article Multidisciplinary Sciences

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

Daniele V. F. Tauriello et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle

Gang Wang et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer

Yen-An Tang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Geriatrics & Gerontology

Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients

Nelson Inacio Pinto Neto et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)

Review Medicine, Research & Experimental

The role of adipose tissue in cancer-associated cachexia

Janina A. Vaitkus et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2017)

Review Medicine, Research & Experimental

TNF-α and cancer cachexia: Molecular insights and clinical implications

Hetal J. Patel et al.

LIFE SCIENCES (2017)

Review Cell Biology

Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation

Brandon N. VanderVeen et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Review Cell Biology

Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism

Justin P. Hardee et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Article Pharmacology & Pharmacy

XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts

Koichiro Kamio et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)

Review Multidisciplinary Sciences

Modeling the process of human tumorigenesis

Sneha Balani et al.

NATURE COMMUNICATIONS (2017)

Editorial Material Geriatrics & Gerontology

Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017

Stephan von Haehling et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)

Review Medicine, General & Internal

The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance

Sunjida Ahmed et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Review Biochemistry & Molecular Biology

The good and the bad faces of STAT1 in solid tumours

Katrin Meissl et al.

CYTOKINE (2017)

Review Pharmacology & Pharmacy

Drug targeting to myofibroblasts: Implications for fibrosis and cancer

Saleh Yazdani et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Article Medicine, Research & Experimental

STAT3 promotes IFNγ/TNFα-induced muscle wasting in an NF-κB-dependent and IL-6-independent manner

Jennifer F. Ma et al.

EMBO MOLECULAR MEDICINE (2017)

Article Oncology

Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway

Michele Joana Alves et al.

BMC CANCER (2017)

Review Immunology

Transforming growth factor β: a master regulator of the gut microbiota and immune cell interactions

David Bauche et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)

Article Oncology

Interleukin-8: A potent promoter of angiogenesis in gastric cancer

Jun Shi et al.

ONCOLOGY LETTERS (2016)

Article Geriatrics & Gerontology

Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients

Miguel L. Batista et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)

Review Cell Biology

Mechanisms of metabolic dysfunction in cancer-associated cachexia

Michele Petruzzelli et al.

GENES & DEVELOPMENT (2016)

Article Biochemistry & Molecular Biology

In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients

Savvas Petanidis et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)

Article Medicine, General & Internal

CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade

Xiangyi Kong et al.

MEDICINE (2016)

Review Cell Biology

Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia

Maria Tsoli et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)

Review Gastroenterology & Hepatology

Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer

Simona Gurzu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Review Oncology

Understanding cachexia as a cancer metabolism syndrome

P. E. Porporato

ONCOGENESIS (2016)

Review Biochemistry & Molecular Biology

Mechanisms and Applications of Interleukins in Cancer Immunotherapy

Doxakis Anestakis et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Review Oncology

Role of TGFβ in regulation of the tumor microenvironment and drug delivery

Panagiotis Papageorgis et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2015)

Article Endocrinology & Metabolism

Role of Activin A and Myostatin in Human Cancer Cachexia

Audrey Loumaye et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Review Biochemistry & Molecular Biology

The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship

Boris Hinz

MATRIX BIOLOGY (2015)

Article Multidisciplinary Sciences

Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling

Gani Oruqaj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Immunology

Systemic Inflammation in Cachexia - Is Tumor Cytokine Expression Profile the Culprit?

Emidio M. de Matos-Neto et al.

FRONTIERS IN IMMUNOLOGY (2015)

Article Oncology

Novel function of Oncostatin M as a potent tumour-promoting agent in lung

Sean Lauber et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Multidisciplinary Sciences

CXCR3 Signaling in BRAFWT Melanoma Increases IL-8 Expression and Tumorigenicity

Molly H. Jenkins et al.

PLOS ONE (2015)

Article Oncology

Emerging markers of cachexia predict survival in cancer patients

Patrizia Mondello et al.

BMC CANCER (2014)

Review Endocrinology & Metabolism

Ghrelin: from discovery to cancer cachexia therapy

Alessio Molfino et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2014)

Article Multidisciplinary Sciences

Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers

Georgia Hatzivassiliou et al.

NATURE (2013)

Article Clinical Neurology

Markers of angiogenesis (CD31, CD34, rCBV) and their prognostic value in low-grade gliomas

Krzysztof Majchrzak et al.

NEUROLOGIA I NEUROCHIRURGIA POLSKA (2013)

Article Biochemistry & Molecular Biology

Adipose tissue inflammation and cancer cachexia: Possible role of nuclear transcription factors

M. L. Batista et al.

CYTOKINE (2012)

Article Endocrinology & Metabolism

Exercise Training Decreases Adipose Tissue Inflammation in Cachectic Rats

F. S. Lira et al.

HORMONE AND METABOLIC RESEARCH (2012)

Article Otorhinolaryngology

Significance of Autopsy in Patients with Head and Neck Cancer

A. M. Sesterhenn et al.

LARYNGO-RHINO-OTOLOGIE (2012)

Review Gastroenterology & Hepatology

Cancer Cachexia: Mechanisms and Clinical Implications

Claire L. Donohoe et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2011)

Editorial Material Nutrition & Dietetics

Cachexia: A new definition

William J. Evans et al.

CLINICAL NUTRITION (2008)

Article Gastroenterology & Hepatology

Impaired glucose metabolism in colorectal cancer

Agnieszka Ehrmann-Josko et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)